News

Jul 04, 2022 Knight Therapeutics announces relaunch of AKYNZEO® in Brazil

Jun 07, 2022 Knight to Present at the 2022 BIO International Convention in San Diego

Jun 03, 2022 Knight to Present at the Jefferies 2022 Healthcare Conference in New York City

Jun 01, 2022 Knight Therapeutics Assumes Commercial Activities for Exelon in Colombia

May 24, 2022 Knight Therapeutics Enters into Exclusive License and Supply Agreements with Rigel Pharmaceuticals to Commercialize Fostamatinib in Latin America

May 12, 2022 Knight Therapeutics Reports First Quarter 2022 Results

May 12, 2022 Knight Therapeutics and Helsinn Healthcare SA Enter into Exclusive License, Distribution, and Supply Agreement for Akynzeo® and Aloxi®

May 11, 2022 Knight to Present at the 2022 RBC Capital Markets Global Healthcare Conference in New York City

May 11, 2022 Knight Therapeutics Inc. announces voting results from the Annual Meeting

May 05, 2022 Notice of Knight Therapeutics' First Quarter 2022 Results Conference Call

<< < > >>